Signia Integrated Xperience Hearing Aid Platform Named a Winner of the 2024 BIG Innovation Awards

Signia Integrated Xperience (IX)

Hearing aid innovator Signia has been named a winner of the 2024 BIG Innovation Awards for its Signia Integrated Xperience (IX) hearing aid platform, which provides unprecedented sound clarity and definition for wearers in noisy group conversations – even when the wearer or speakers are in motion. The recognition underscores the company’s commitment to delivering groundbreaking solutions to all hearing aid wearers that optimize hearing capabilities in even the most challenging listening scenarios.

BIG Innovation Awards

The BIG Innovation Awards recognize organizations and products that deliver premium innovation across verticals, bringing new ideas to life that will improve the lives of users and businesses. The new Signia Integrated Xperience hearing aid platform was recognized in the Healthcare category. Past BIG Innovation Award winners include Citi Ventures, Walgreens Boots Alliance, Velcro®, Bloomfire, and Colgate-Palmolive.

“The Signia Integrated Xperience platform is truly revolutionary in its ability to deliver maximum value and unparalleled hearing capabilities to all wearers, and it’s an honor to see that innovation recognized by such a prestigious award program,” said Mike O’Neil, President of Signia U.S. “Developing advanced hearing technology to best support hearing care professionals and their patients is at the core of Signia’s mission, and the Integrated Xperience platform does just that by pushing the boundaries of what hearing technology can do.”

As the world’s first hearing aid platform capable of pinpointing multiple conversation partners in real-time, Signia’s Integrated Xperience leverages insights into the changing positions of speakers to ensure uninterrupted engagement in even the most noisy, immersive environments.

Signia’s RealTime Conversation Enhancement

Integrated Xperience features Signia’s RealTime Conversation Enhancement solution that analyzes, augments, and adapts to the dynamic flow of multi-party conversation environments. The technology works in three stages, allowing wearers to engage, interact, and participate in noisy group conversations regardless of location, movement, and noise level.

The Integrated Xperience platform is currently available in Signia’s Pure Charge&Go IX and Silk Charge&Go IX hearing aid models, offering a substantial improvement in conversational ability for patients.

“The hearing aids built on Signia’s Integrated Xperience platform ultimately allow wearers to enjoy more meaningful lives with richer conversations,” said Nicholas Hort, Vice President of Marketing for Signia U.S. “With Integrated Xperience, we’ve set a new industry standard for hearing aid technology, prioritizing socialization, engagement, and a level of hearing ability that was previously unattainable in noisy, busy scenarios.”

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.